AN2 Therapeutics, Inc. (ANTX) Earnings Report - Discounting Cash Flows
ANTX
AN2 Therapeutics, Inc.
ANTX (NASDAQ)
Period Ending: 2026
04-01
2026
03-24
2025
11-12
2025
08-12
2025
05-13
2025
03-25
2024
11-13
2024
08-13
2024
05-14
2024
03-28
2023
11-09
2023
08-10
2023
05-11
2023
03-29
2022
11-09
2022
08-11
2022
05-10
2022
03-28
2021
12-31
2021
06-29
2021
03-30
Actual EPS - - -0.31 -0.21 -0.35 -0.25 -0.43 -0.48 -0.56 -0.57 -0.65 -0.81 -0.79 -0.61 -0.59 -0.53 -2.98 -0.49 -0.42 -0.36 -0.15
Estimated EPS -0.24 -0.24 -0.23 -0.31 -0.26 -0.25 -0.37 -0.63 -0.61 -0.71 -0.63 -0.85 -0.68 -0.63 -0.59 -0.45 -0.52 - - - -
Actual Revenue - - - - - - - - - 0.08 - - - - - - - - - - -
Estimated Revenue - - - - - - - - - - - - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program